| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |